首页 | 本学科首页   官方微博 | 高级检索  
     


Double targeting of tumours with pyrenyl-modified dendrimers encapsulated in an arene-ruthenium metallaprism
Authors:Pitto-Barry Anaïs  Barry Nicolas P E  Zava Olivier  Deschenaux Robert  Dyson Paul J  Therrien Bruno
Affiliation:Institut de Chimie, Université de Neuchatel, Avenue de Bellevaux 51, 2000 Neuchatel, Switzerland.
Abstract:The self‐assembly of 2,4,6‐tris(pyridin‐4‐yl)‐1,3,5‐triazine (tpt) triangular panels with p‐cymene–ruthenium building blocks and 5,8‐dioxido‐1,4‐naphthoquinonato (donq) bridges, in the presence of pyrenyl‐containing dendrimers of different generations (P0, P1 and P2), affords the triangular prismatic host–guest compounds [Pn?Ru6(p‐cymene)6(tpt)2(donq)3]6+ ([Pn? 1 ]6+). The host–guest nature of these systems, with the pyrenyl moiety being encapsulated in the hydrophobic cavity of the cage and the dendritic functional group pointing outwards, was confirmed by NMR spectroscopy (1H, 2D and DOSY). The host–guest properties of these systems were studied in solution by NMR and UV/Vis spectroscopic methods, allowing the determination of their affinity constants (Ka). Moreover, the ability of these water‐soluble host–guest systems to carry the pyrenyl‐containing dendrimers into cancer cells was evaluated on human ovarian cancer cells. The host–guest systems are all more cytotoxic than the empty cage [ 1 ][CF3SO3]6 (IC50≈4 μM ), with the most active compound, [P0? 1 ][CF3SO3]6, being an order of magnitude more cytotoxic.
Keywords:antitumor agents  dendrimers  drug delivery  host–guest systems  metallaprisms
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号